Tadashi Watabe

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 34

Top Topics

Positron Emission Tomography

Top Venues

Annals of nuclear medicine

International journal of molecular sciences

EJNMMI radiopharmacy and chemistry

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, Noriyuki Tomiyama, Makoto Hosono
Manual on the proper use of the 211 At-labeled PSMA ligand ([ 211 At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of nuclear medicine (2024)
Sadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, Kenta Kurimoto, Toshihiro Sakai, Kazuhiro Takahashi, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Hiroki Kato, Noriyuki Tomiyama, Tadashi Watabe
Production of [ 211 At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Yuta Kaizuka, Hiroyuki Suzuki, Tadashi Watabe, Kazuhiro Ooe, Atsushi Toyoshima, Kazuhiro Takahashi, Koichi Sawada, Takashi Iimori, Yoshitada Masuda, Takashi Uno, Kento Kannaka, Tomoya Uehara
Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, Noriyuki Tomiyama, Makoto Hosono
Manual on the proper use of the 211 At-labeled PSMA ligand ([ 211 At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of nuclear medicine 38 (5) (2024)
Sadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, Kenta Kurimoto, Toshihiro Sakai, Kazuhiro Takahashi, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Hiroki Kato, Noriyuki Tomiyama, Tadashi Watabe
Production of [ 211 At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuhiro Ooe, Thosapol Sampunta, Naoki Hirose, Xiaojie Yin, Hiromitsu Haba, Yukiyoshi Kon, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Koichi Fukase, Noriyuki Tomiyama, Yoshifumi Shirakami
Preclinical Evaluation of Biodistribution and Toxicity of [ 211 At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer. International journal of molecular sciences 25 (11) (2024)
Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuhiro Ooe, Thosapol Sampunta, Naoki Hirose, Xiaojie Yin, Hiromitsu Haba, Yukiyoshi Kon, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Koichi Fukase, Noriyuki Tomiyama, Yoshifumi Shirakami
Preclinical Evaluation of Biodistribution and Toxicity of [ 211 At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer. International journal of molecular sciences 25 (11) (2024)
Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, Noriyuki Tomiyama, Makoto Hosono
Manual on the proper use of the 211 At-labeled PSMA ligand ([ 211 At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of nuclear medicine 38 (5) (2024)
Yuta Kaizuka, Hiroyuki Suzuki, Tadashi Watabe, Kazuhiro Ooe, Atsushi Toyoshima, Kazuhiro Takahashi, Koichi Sawada, Takashi Iimori, Yoshitada Masuda, Takashi Uno, Kento Kannaka, Tomoya Uehara
Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuhiro Ooe, Thosapol Sampunta, Naoki Hirose, Xiaojie Yin, Hiromitsu Haba, Yukiyoshi Kon, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Koichi Fukase, Noriyuki Tomiyama, Yoshifumi Shirakami
Preclinical Evaluation of Biodistribution and Toxicity of [ 211 At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer. International journal of molecular sciences 25 (11) (2024)
Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, Noriyuki Tomiyama, Makoto Hosono
Manual on the proper use of the 211 At-labeled PSMA ligand ([ 211 At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of nuclear medicine 38 (5) (2024)
Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, Noriyuki Tomiyama, Makoto Hosono
Manual on the proper use of the 211 At-labeled PSMA ligand ([ 211 At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of nuclear medicine 38 (5) (2024)
Sadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, Kenta Kurimoto, Toshihiro Sakai, Kazuhiro Takahashi, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Hiroki Kato, Noriyuki Tomiyama, Tadashi Watabe
Production of [ 211 At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Sadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, Kenta Kurimoto, Toshihiro Sakai, Kazuhiro Takahashi, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Hiroki Kato, Noriyuki Tomiyama, Tadashi Watabe
Production of [ 211 At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, Noriyuki Tomiyama, Makoto Hosono
Manual on the proper use of the 211 At-labeled PSMA ligand ([ 211 At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of nuclear medicine 38 (5) (2024)
Tadashi Watabe, Ivan Ray David, Toru Kimura, Takashi Hiroshima, Mitsuaki Tatsumi, Sadahiro Naka, Takashi Kamiya, Eriko Fukui, Takashi Kanou, Naoko Ose, Soichiro Funaki, Yuriko Mori, Jens Cardinale, Hiroki Kato, Eiichi Morii, Yasushi Shintani, Frederik L Giesel
Epithelioid granuloma mimicking lung cancer showed intense uptake on [ 18 F]FAPI-74 PET. European journal of nuclear medicine and molecular imaging (2023)
Ayaka Aso, Hinako Nabetani, Yoshifumi Matsuura, Yuichiro Kadonaga, Yoshifumi Shirakami, Tadashi Watabe, Taku Yoshiya, Masayoshi Mochizuki, Kazuhiro Ooe, Atsuko Kawakami, Naoya Jinno, Atsushi Toyoshima, Hiromitsu Haba, Yang Wang, Jens Cardinale, Frederik Lars Giesel, Atsushi Shimoyama, Kazuko Kaneda-Nakashima, Koichi Fukase
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine. International journal of molecular sciences 24 (10) (2023)
Tadashi Watabe, Takahito Fukusumi, Hidenori Inohara, Mitsuaki Tatsumi, Sadahiro Naka, Takashi Kamiya, Hiroki Kato, Yuriko Mori, Jens Cardinale, Frederik L Giesel
Activated fibroblasts in muscle sarcoidosis revealed by [ 18 F]FAPI-74 PET. European journal of nuclear medicine and molecular imaging (2023)
Tadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Kazuhiro Ooe, Yang Wang, Hiromitsu Haba, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Noriyuki Tomiyama, Koichi Fukase
Targeted α-therapy using astatine ( 211 At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound. European journal of nuclear medicine and molecular imaging (2022)
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Tadashi Watabe, Kazuhiro Ooe, Takashi Yoshimura, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Koichi Fukase
Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter. International journal of molecular sciences 23 (24) (2022)
Tadashi Watabe
Response to the letter to the editor. Annals of nuclear medicine 36 (9) (2022)
Kensuke Suzuki, Hiroshi Iwai, Keita Utsunomiya, Yumiko Kono, Tadashi Watabe, Yoshiki Kobayashi, Dan Van Bui, Shunsuke Sawada, Yasutaka Yun, Akitoshi Mitani, Kenta Fukui, Haruka Sakai, Hanh Hong Chu, Nguyen Manh Linh, Noboru Tanigawa, Akira Kanda
Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model. International journal of molecular sciences 23 (17) (2022)
Tadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, Tatsuhiko Sato, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Eku Shimosegawa, Yang Wang, Hiromitsu Haba, Takashi Nakano, Atsushi Shinohara, Jun Hatazawa
Comparison of the Therapeutic Effects of [ 211 At]NaAt and [ 131 I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model. International journal of molecular sciences 23 (16) (2022)
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Tadashi Watabe, Kazuhiro Ooe, Takashi Yoshimura, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Koichi Fukase
Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter. International journal of molecular sciences 23 (24) (2022)
Barbara Hertz, Tadashi Watabe, Richard P Baum
Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranostics. Annals of nuclear medicine 36 (12) (2022)
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Tadashi Watabe, Kazuhiro Ooe, Takashi Yoshimura, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Koichi Fukase
Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter. International journal of molecular sciences 23 (24) (2022)
Hirofumi Hanaoka, Yasuhiro Ohshima, Hiroyuki Suzuki, Ichiro Sasaki, Tadashi Watabe, Kazuhiro Ooe, Shigeki Watanabe, Noriko S Ishioka
Enhancing the Therapeutic Effect of 2-211At-astato-α-methyl-L-phenylalanine with Probenecid Loading. Cancers 13 (21) (2021)
Tadashi Watabe, Makoto Hosono, Seigo Kinuya, Takahiro Yamada, Sachiko Yanagida, Masao Namba, Yoshihide Nakamura
Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition). Annals of nuclear medicine 35 (7) (2021)
Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yuwei Liu, Kenta Kurimoto, Takashi Murai, Yuka Shidahara, Kenji Okuma, Masanori Takeuchi, Masayuki Nishide, Atsushi Toyoshima, Atsushi Shinohara, Yoshifumi Shirakami
Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer. Annals of nuclear medicine 35 (6) (2021)
Tadashi Watabe, Motohide Uemura, Fumihiko Soeda, Sadahiro Naka, Takeshi Ujike, Koji Hatano, Hidetaka Sasaki, Takashi Kamiya, Eku Shimosegawa, Hiroki Kato, Jens Cardinale, Ukihide Tateishi, Norio Nonomura, Frederik L Giesel
High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients. Annals of nuclear medicine 35 (4) (2021)
Hiroki Matsumoto, Tadashi Watabe, Chika Igarashi, Tomoko Tachibana, Fukiko Hihara, Atsuo Waki, Ming-Rong Zhang, Hideaki Tashima, Taiga Yamaya, Kazuhiro Ooe, Eku Shimosegawa, Jun Hatazawa, Sei Yoshida, Kenichiro Naito, Hiroaki Kurihara, Makoto Ueno, Kimiteru Ito, Tatsuya Higashi, Yukie Yoshii
Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Kazuko Kaneda-Nakashima, ZiJian Zhang, Yoshiyuki Manabe, Atsushi Shimoyama, Kazuya Kabayama, Tadashi Watabe, Yoshikatsu Kanai, Kazuhiro Ooe, Atsushi Toyoshima, Yoshifumi Shirakami, Takashi Yoshimura, Mitsuhiro Fukuda, Jun Hatazawa, Takashi Nakano, Koichi Fukase, Atsushi Shinohara
α-Emitting cancer therapy using 211 At-AAMT targeting LAT1. Cancer science 112 (3) (2021)
Yuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Sadahiro Naka, Kazuhiro Ooe, Atsushi Toyoshima, Kojiro Nagata, Uwe Haberkorn, Clemens Kratochwil, Atsushi Shinohara, Jun Hatazawa, Frederik Giesel
Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. European journal of nuclear medicine and molecular imaging (2021)
Kosuke Mitsuyuki, Tadashi Watabe, Sadahiro Naka, Yuwei Liu, Mitsuaki Tatsumi, Eku Shimosegawa, Hiroki Kato
Evaluation of Integrin αvβ3 Expression in Murine Xenograft Models: [68Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation. Diagnostics (Basel, Switzerland) 11 (7) (2021)